Physiomics secures 'substantial new contract' with existing pharma client

18th Mar 2024 09:43

(Sharecast News) - Mathematical modelling and data science company Physiomics has been awarded "a substantial new contract" by an existing large pharmaceutical client.

Physiomics said on Monday that the project involves Pharmacokinetic-Pharmacodynamic modelling in the field of DNA damage/repair field and will help inform clinical dose and scheduling decisions.

The AIM-listed group added that the value of the project was £178k,000 and it was anticipated that it would be completed over the course of the next six months.

Chief executive Peter Sargent said: "We are very pleased that we've been awarded this substantial project and we very much look forward to working with the client team on this exciting project".

As of 0940 GMT, Physiomics shares had shot up 8.00% to 1.35p.

Reporting by Iain Gilbert at Sharecast.com

Top Risers

Share	Price	Change
Guardian Metal Resources PLC (GMET)	28.50	21.28%
Jade Road Inv (JADE)	0.12	20%
Mothercare (MTC)	4.25	17.4%
Eco Buildings (ECOB)	6.75	17.39%
Tungsten west (TUN)	2.625	16.15%

Top Fallers

Share	Price	Change
Enwell Energy (ENW)	16.50	-35.66%
Celadon Pharma. (CEL)	17.00	-29.29%
Webis (WEB)	0.475	-20.83%
Autins Group (AUTG)	7.00	-17.65%
Genip Plc (GNIP)	19.00	-11.63%

Top By Volume

Share	Price	Volume
Tower Resources (TRP)	0.029	776,952,248
Mosman Oil Gas (MSMN)	0.044	350,120,826
Red Rock Resources (RRR)	0.05	148,472,969
Nativo Resources (NTVO)	0.0023	144,984,331
Vela Technologies (VELA)	0.0055	127,123,158

All prices are delayed by at least 15 minutes. Share Compare cannot be held responsible for the accuracy of share prices shown on this website, and investors should be aware that share prices can go down as well as up. Share Compare does not offer advice, and is not regulated by the Financial Conduct Authority.